Interactive Drug Benefit List
DIN/NPN/ PIN Generic Name Product Name, Strength & Dosage Form Unit Price, Unit of Issue Manufacturer LCA Price MAC Price Interchangeable Products Coverage Status
02415992 AFLIBERCEPT EYLEA 2 MG / VIAL INJECTION 1,418.0000
VIAL
BAI N/A N/A NO RESTRICTED BENEFIT Details
02496976 BROLUCIZUMAB BEOVU 6 MG / SYR INJECTION SYRINGE 1,390.0000
SYR
NOV N/A N/A NO RESTRICTED BENEFIT Details
02425629 RANIBIZUMAB LUCENTIS 1.65 MG / SYR INJECTION N/A
SYR
NOV N/A N/A NO NOT A BENEFIT Details
02525852 RANIBIZUMAB BYOOVIZ 2.3 MG / VIAL INJECTION N/A
VIAL
SSB N/A N/A NO UNDER REVIEW Details
02296810 RANIBIZUMAB LUCENTIS 2.3 MG / VIAL INJECTION 1,679.5900
VIAL
NOV N/A N/A NO RESTRICTED BENEFIT Details
DIN/NPN/ PIN 02415992
Generic Name AFLIBERCEPT
Product Name, Strength & Dosage Form EYLEA 2 MG / VIAL INJECTION
Unit Price, Unit of Issue 1,418.0000
Manufacturer BAI
LCA Price N/A
MAC Price N/A
Interchangeable Products NO
Coverage Status RESTRICTED BENEFIT
Details
DIN/NPN/ PIN 02496976
Generic Name BROLUCIZUMAB
Product Name, Strength & Dosage Form BEOVU 6 MG / SYR INJECTION SYRINGE
Unit Price, Unit of Issue 1,390.0000
Manufacturer NOV
LCA Price N/A
MAC Price N/A
Interchangeable Products NO
Coverage Status RESTRICTED BENEFIT
Details
DIN/NPN/ PIN 02425629
Generic Name RANIBIZUMAB
Product Name, Strength & Dosage Form LUCENTIS 1.65 MG / SYR INJECTION
Unit Price, Unit of Issue N/A
Manufacturer NOV
LCA Price N/A
MAC Price N/A
Interchangeable Products NO
Coverage Status NOT A BENEFIT
Details
DIN/NPN/ PIN 02525852
Generic Name RANIBIZUMAB
Product Name, Strength & Dosage Form BYOOVIZ 2.3 MG / VIAL INJECTION
Unit Price, Unit of Issue N/A
Manufacturer SSB
LCA Price N/A
MAC Price N/A
Interchangeable Products NO
Coverage Status UNDER REVIEW
Details
DIN/NPN/ PIN 02296810
Generic Name RANIBIZUMAB
Product Name, Strength & Dosage Form LUCENTIS 2.3 MG / VIAL INJECTION
Unit Price, Unit of Issue 1,679.5900
Manufacturer NOV
LCA Price N/A
MAC Price N/A
Interchangeable Products NO
Coverage Status RESTRICTED BENEFIT
Details
To return to the printable Drug Benefit List and related publications, click here
Last Updated:
NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.
Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.
Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.